TransMedics Group, Inc. $TMDX reported second-quarter 2026 revenue of $189.9 million, up 20.7% from a year earlier and slightly ahead of the $187.3 million estimate. Gross profit rose to $113.2 million, also reflecting solid top-line growth.
Profitability was more pressured during the quarter. Operating profit fell 35.1% to $23.7 million, while net income attributable to common shareholders dropped 57.9% to $14.7 million. Diluted earnings per share came in at $0.41, below the $0.48 estimate.
Cash flow weakened sharply, with operating cash flow at $17.3 million. The company ended the quarter with $472.7 million in cash and cash equivalents, while total liabilities increased to $946.3 million. Shares rose 9.62% after the market close.
- Revenue: $189.9 million, up 20.7% year over year
- Gross profit: $113.2 million
- Diluted EPS: $0.41
- Cash and cash equivalents: $472.7 million
- Total liabilities: $946.3 million
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
TransMedics Group, Inc. Insider Trading Activity
TransMedics Group, Inc. insiders have traded $TMDX stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $TMDX stock by insiders over the last 6 months:
- GERARDO HERNANDEZ (Chief Financial Officer) has made 0 purchases and 3 sales selling 7,611 shares for an estimated $1,117,381.
- THOMAS J. GUNDERSON sold 9,624 shares for an estimated $722,377
- DAVID WEILL sold 3,571 shares for an estimated $524,294
- NICHOLAS CORCORAN (See remarks) sold 2,966 shares for an estimated $412,629
- STEPHANIE LOVELL sold 1,193 shares for an estimated $178,496
- ANIL P. RANGANATH (See remarks) sold 864 shares for an estimated $120,199
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
TransMedics Group, Inc. Hedge Fund Activity
We have seen 182 institutional investors add shares of TransMedics Group, Inc. stock to their portfolio, and 214 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 671,927 shares (-94.4%) from their portfolio in Q1 2026, for an estimated $66,796,263
- CONGRESS ASSET MANAGEMENT CO added 227,834 shares (+inf%) to their portfolio in Q2 2026, for an estimated $15,132,734
- PRICE T ROWE ASSOCIATES INC /MD/ removed 223,287 shares (-39.2%) from their portfolio in Q1 2026, for an estimated $22,196,960
- MARSHALL WACE, LLP removed 174,824 shares (-91.8%) from their portfolio in Q1 2026, for an estimated $17,379,253
- MILLENNIUM MANAGEMENT LLC added 157,049 shares (+105.4%) to their portfolio in Q1 2026, for an estimated $15,612,241
- CAPITAL WORLD INVESTORS added 146,736 shares (+64.5%) to their portfolio in Q1 2026, for an estimated $14,587,025
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 133,875 shares (+inf%) to their portfolio in Q1 2026, for an estimated $13,308,513
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
TransMedics Group, Inc. Price Targets
Multiple analysts have issued price targets for $TMDX recently. We have seen 9 analysts offer price targets for $TMDX in the last 6 months, with a median target of $120.0.
Here are some recent targets:
- Daniel Markowitz from Evercore ISI Group set a target price of $90.0 on 07/06/2026
- Joshua Jennings from TD Cowen set a target price of $120.0 on 07/01/2026
- William Plovanic from Canaccord Genuity set a target price of $124.0 on 06/30/2026
- Tom Stephan from Stifel set a target price of $80.0 on 06/18/2026
- Matt O'Brien from Piper Sandler set a target price of $120.0 on 05/06/2026
- Mike Matson from Needham set a target price of $142.0 on 05/06/2026
- Allen Gong from JP Morgan set a target price of $149.0 on 02/25/2026
